UA59444U - Method for selecting hypolipidemic therapy in female patients with metabolic syndrome aged over 50 - Google Patents

Method for selecting hypolipidemic therapy in female patients with metabolic syndrome aged over 50

Info

Publication number
UA59444U
UA59444U UAU201014845U UAU201014845U UA59444U UA 59444 U UA59444 U UA 59444U UA U201014845 U UAU201014845 U UA U201014845U UA U201014845 U UAU201014845 U UA U201014845U UA 59444 U UA59444 U UA 59444U
Authority
UA
Ukraine
Prior art keywords
selecting
metabolic syndrome
female patients
aged over
hypolipidemic therapy
Prior art date
Application number
UAU201014845U
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Елена Ивановна Митченко
Алла Алексеевна Логвиненко
Вадим Юрьевич Романов
Екатерина Александровна Яновская
Ирина Вацлавовна Чулаевская
Original Assignee
Национальный Научный Центр "Институт Кардиологии Имени Академика Н.Д. Стражеско" Амн Украины
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Национальный Научный Центр "Институт Кардиологии Имени Академика Н.Д. Стражеско" Амн Украины filed Critical Национальный Научный Центр "Институт Кардиологии Имени Академика Н.Д. Стражеско" Амн Украины
Priority to UAU201014845U priority Critical patent/UA59444U/en
Publication of UA59444U publication Critical patent/UA59444U/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

A method for selecting the hypolipidemic therapy in the female patients with metabolic syndrome aged over 50 provides for examination followed by Atorvastatin treatment prescribed based on the results of examination. When 3 months of Atorvastatin treatment is not highly effective, thyrotropin blood content is assayed. When thyrotropin blood content exceeds 4.0 mU/mL, Levothyroxin sodium is used at the doses selected on an individual basis.
UAU201014845U 2010-12-10 2010-12-10 Method for selecting hypolipidemic therapy in female patients with metabolic syndrome aged over 50 UA59444U (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UAU201014845U UA59444U (en) 2010-12-10 2010-12-10 Method for selecting hypolipidemic therapy in female patients with metabolic syndrome aged over 50

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UAU201014845U UA59444U (en) 2010-12-10 2010-12-10 Method for selecting hypolipidemic therapy in female patients with metabolic syndrome aged over 50

Publications (1)

Publication Number Publication Date
UA59444U true UA59444U (en) 2011-05-10

Family

ID=50833394

Family Applications (1)

Application Number Title Priority Date Filing Date
UAU201014845U UA59444U (en) 2010-12-10 2010-12-10 Method for selecting hypolipidemic therapy in female patients with metabolic syndrome aged over 50

Country Status (1)

Country Link
UA (1) UA59444U (en)

Similar Documents

Publication Publication Date Title
MX2014005996A (en) Anti-adrenomedullin (adm) antibody or anti-adm antibody fragment or an anti-adm non-ig scaffold for use in therapy.
MY178654A (en) Anti-adrenomedullin (adm) antibody or anti-adm antibody fragment or an anti-adm non-ig protein scaffold for use in therapy
WO2015054619A8 (en) Use of a pcsk9 inhibitor to treat hyperlipidemia
IN2012DN06309A (en)
EA201170669A1 (en) TREATMENT OF PYRPHENIDONE PATIENTS WITH ATYPICAL LIVER FUNCTION
NZ609201A (en) Means and methods for treating dlbcl
IN2012DN03172A (en)
EP4327886A3 (en) Pyrimido- pyridazinone compounds and use thereof
NZ598722A (en) Methods for treating psoriasis
JP2015537000A5 (en)
WO2012063134A3 (en) Cardiac glycoside analogs in combination with emodin for cancer therapy
NZ754328A (en) Marker for acid sphingomyelinase disorders and uses thereof
NZ604009A (en) A combination composition comprising ibuprofen and paracetamol
UA59444U (en) Method for selecting hypolipidemic therapy in female patients with metabolic syndrome aged over 50
UA109944U (en) PHARMACEUTICAL COMPOSITION TO REDUCE THE N-OXIDE OF TRIMETHYLAMINE LEVEL
WO2011133479A3 (en) Combination therapy with a proteasome inhibitor and a gallium complex
MX2023006765A (en) Method of providing celiprolol therapy to a patient.
UA49534U (en) Method for optimizing treatment of heart failure in aged patients after myocardial infarction
RU2011118837A (en) METHOD FOR PREDICTION OF DENTAL HIV-INFECTED PATIENTS UNDER THE CONDITIONS OF OUTDOOR DENTAL RECEPTION
UA35015U (en) Method for immunorehabilitation of patients with metabolic syndrome
UA84715U (en) Method for treating diabetes mellitus type 2 with obesity
UA70016U (en) Method for correction of melatonin-forming epiphysis function in patients with hypertension
UA82250U (en) Method for treating patients with non-alcoholic fatty liver disease
UA95574C2 (en) Method for treatment of infertility in patients with syndrome of weak response of ovaries
UA66406U (en) Method for preventing osteopenic syndrome in pregnant patients with perinatal infection